Newsroom

NEW YORK--(BUSINESS WIRE)--Super Group (SGHC) Limited (NYSE: SGHC) (“SGHC” or “Super Group”), the parent company of Betway, a leading online sports betting and gaming business, and Spin, the multi-brand online casino, today provided a business update for the fourth quarter and full-year 2025, and announced a special dividend. Super Group delivered another year of robust growth. Casino continued to perform exceptionally well, providing a resilient foundation for overall profitability. While cust...

FRANKFURT--(BUSINESS WIRE)--Board, eine der führenden Enterprise-Planning-Plattformen, gab heute die Einführung der Board Agents bekannt, die auf Microsoft Foundry basieren. Board Agents liefern eine intelligente Suite domänenspezifischer, Enterprise-fähiger KI-Agents, die reale Planungsentscheidungen in den Bereichen Finance, Supply Chain und Merchandising unterstützen. Dies ist die erste Enterprise-Planning-Funktion von Board, die mit Microsoft Foundry entwickelt wurde und die agentischen KI-...

ELGIN, Ill.--(BUSINESS WIRE)--SureWerx®, a leading global provider of safety, tool & equipment products, is pleased to announce the upcoming launch of Dickies® Safety Footwear, a comprehensive new footwear platform set for delivery in the fourth quarter of this year. Built on over a century of workwear authenticity, the Dickies® Safety Footwear collection delivers jobsite-ready performance without compromise. The lineup will include a broad range of safety-toe and soft-toe options engineere...

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) disease, following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). AQNEURSA® is approved in the European Union for use in adults and children aged 6 years and older weighing at least 20 kg. Th...

MIAMI--(BUSINESS WIRE)--OpenEvidence, the most widely-used AI platform by doctors in America, announced today that it closed a Series D round of funding, valuing the company at $12 billion. This makes OpenEvidence the most valuable Healthcare AI company in the world. OpenEvidence is a specialized AI-powered medical search engine that serves as a "brain extender" for clinicians by providing real-time, citation-linked answers synthesized exclusively from the world’s most trusted, peer-reviewed me...

SHORT HILLS, N.J.--(BUSINESS WIRE)--Raaj Rajmangal succeeds Founder Martin Wise as the company’s Chief Executive Officer. Wise transitions to Executive Chairman....

IRVINE, Calif.--(BUSINESS WIRE)--Cotality has been named a winner in Glassdoor’s inaugural Best Places to Work in Technology and AI for 2026. The list is a new addition to Glassdoor’s 18th annual Employees’ Choice Awards, honoring the Best Places to Work. Unlike other workplace awards, the Glassdoor Employees’ Choice Awards are based on the input of employees who voluntarily provide anonymous feedback on Glassdoor by completing a company review about their job, work environment, and employer ov...

RALEIGH, N.C.--(BUSINESS WIRE)--Digital.ai, the only AI-powered software delivery platform for the enterprise, today announced industry-first support for end-to-end automated testing of Android Auto and Apple CarPlay apps, expanding its automotive testing capabilities that already support AAOS and mobile-to-vehicle integrations. Digital.ai is now the only provider enabling enterprise teams to automate critical in-car app workflows, expand coverage, and validate real-world behavior at scale with...

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. today announced positive topline results from its pivotal Phase III IB1001-303 clinical trial, “Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, Placebo-Controlled, Double-Blind, Crossover Study” (NCT06673056) evaluating N-acetyl-L-leucine (levacetylleucine) in pediatric and adult patients with Ataxia-Telangiectasia (A-T). The primary endpoint of the trial evaluated the effect of treatment with levacetylleucine on the Scal...

LONDON, Ontario--(BUSINESS WIRE)--Fortune Minerals Limited (TSX: FT) (OTCQB: FTMDF) (“Fortune” or the “Company”) (www.fortuneminerals.com) is pleased to announce that it has successfully concluded the validation test work for an optimized hydrometallurgical flowsheet to produce battery grade cobalt sulphate heptahydrate for the NICO cobalt-gold-bismuth-copper project (“NICO Project”) in Canada. The results verified that a high-quality cobalt sulphate heptahydrate product can be generated with v...